Search Results - "CASTELL, José V"

Refine Results
  1. 1

    Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved by Martínez-Sena, Teresa, Moro, Erika, Moreno-Torres, Marta, Quintás, Guillermo, Hengstler, Jan, Castell, José V.

    Published in Archives of toxicology (01-06-2023)
    “…Toxicity studies, among them hepatotoxicity, are key throughout preclinical stages of drug development to minimise undesired toxic effects that might…”
    Get full text
    Journal Article
  2. 2

    The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics by Quintás, Guillermo, Castell, José V, Moreno-Torres, Marta

    Published in Frontiers in pharmacology (05-05-2023)
    “…Drug hepatotoxicity assessment is a relevant issue both in the course of drug development as well as in the post marketing phase. The use of human relevant…”
    Get full text
    Journal Article
  3. 3

    Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways by Petrov, Petar D., Soluyanova, Polina, Sánchez-Campos, Sonia, Castell, José V., Jover, Ramiro

    Published in Food and chemical toxicology (01-12-2021)
    “…Treatment of β-lactamase positive bacterial infections with a combination of amoxicillin (AMOX) and clavulanic acid (CLAV) causes idiosyncratic drug-induced…”
    Get full text
    Journal Article
  4. 4

    A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy by Soluyanova, Polina, del Pozo, Marta, Moro-Castaño, Erika, Marco-Hernández, Ana V., Castell, José V., Jover, Ramiro

    Published in Toxicology (Amsterdam) (01-12-2024)
    “…Valproate (VPA) has been the first-line, most frequently prescribed antiepileptic drug in children over the past 50 years. VPA causes, idiosyncratic…”
    Get full text
    Journal Article
  5. 5

    The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment by Moreno-Torres, Marta, Quintás, Guillermo, Castell, José V.

    Published in Metabolites (19-06-2022)
    “…Drug-induced liver injury (DILI) is one of the most frequent adverse clinical reactions and a relevant cause of morbidity and mortality. Hepatotoxicity is…”
    Get full text
    Journal Article
  6. 6

    A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes by Moreno-Torres, Marta, Kumar, Manoj, García-Llorens, Guillem, Quintás, Guillermo, Tricot, Tine, Boon, Ruben, Tolosa, Laia, Toprakhisar, Burak, Chesnais, Francois, Verfaillie, Catherine, Castell, José V

    Published in Journal of proteome research (04-03-2022)
    “…Typical protocols to differentiate induced pluripotent stem cells (iPSCs) from hepatocyte-like cells (HLCs) imply complex strategies that include transfection…”
    Get full text
    Journal Article
  7. 7

    Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat by Quintás, Guillermo, Caiment, Florian, Rienda, Iván, Pérez-Rojas, Judith, Pareja, Eugenia, Castell, José V, Jover, Ramiro

    “…Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease worldwide, but a reliable non-invasive method to quantify liver…”
    Get full text
    Journal Article
  8. 8

    Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile by Moya, Marta, José Gómez-Lechón, M., Castell, José V., Jover, Ramiro

    Published in Chemico-biological interactions (30-03-2010)
    “…Steatosis is the first step in the development of non-alcoholic fatty liver disease (NAFLD). However, the mechanisms involved in its pathogenesis are not fully…”
    Get full text
    Journal Article
  9. 9

    A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 Patients by Baier, Vanessa, Cordes, Henrik, Thiel, Christoph, Castell, José V., Neumann, Ulf P., Blank, Lars M., Kuepfer, Lars

    Published in Frontiers in physiology (27-09-2019)
    “…Drug-induced liver injury (DILI) is a matter of concern in the course of drug development and patient safety, often leading to discontinuation of…”
    Get full text
    Journal Article
  10. 10

    Comparing Targeted vs. Untargeted MS2 Data-Dependent Acquisition for Peak Annotation in LC–MS Metabolomics by Ten-Doménech, Isabel, Martínez-Sena, Teresa, Moreno-Torres, Marta, Sanjuan-Herráez, Juan Daniel, Castell, José V., Parra-Llorca, Anna, Vento, Máximo, Quintás, Guillermo, Kuligowski, Julia

    Published in Metabolites (26-03-2020)
    “…One of the most widely used strategies for metabolite annotation in untargeted LCMS is based on the analysis of MSn spectra acquired using data-dependent…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Down‐regulation of human CYP3A4 by the inflammatory signal interleukin 6: molecular mechanism and transcription factors involved by Jover, Ramiro, Bort, Roque, Gómez‐Lechón, Ma. José, Castell, José V.

    Published in The FASEB journal (01-11-2002)
    “…The hepatic drug‐metabolizing cytochrome P‐450 (CYP) enzymes are down‐regulated during inflammation. In vitro studies with hepatocytes have shown that the…”
    Get full text
    Journal Article
  13. 13

    Underexpressed Coactivators PGC1α AND SRC1 Impair Hepatocyte Nuclear Factor 4α Function and Promote Dedifferentiation in Human Hepatoma Cells by Martínez-Jiménez, Celia P., Gómez-Lechón, M. José, Castell, José V., Jover, Ramiro

    Published in The Journal of biological chemistry (06-10-2006)
    “…Hepatocyte nuclear factor 4α (HNF4α) plays critical roles during liver development and in the transcriptional regulation of many hepatic genes in adult liver…”
    Get full text
    Journal Article
  14. 14

    The use of hepatocytes to investigate drug toxicity by Gómez-Lechón, María José, Castell, José V, Donato, María Teresa

    “…The liver is very active in metabolizing foreign compounds and the major target for toxicity caused by drugs. Hepatotoxicity may be the result of the drug…”
    Get more information
    Journal Article
  15. 15

    FLUORESCENCE-BASED ASSAYS FOR SCREENING NINE CYTOCHROME P450 (P450) ACTIVITIES IN INTACT CELLS EXPRESSING INDIVIDUAL HUMAN P450 ENZYMES by Donato, M Teresa, Jiménez, Nuria, Castell, José V, Gómez-Lechón, M José

    Published in Drug metabolism and disposition (01-07-2004)
    “…In this study we describe a battery of fluorescence assays for rapid measurement in intact cells of the activity of nine cytochromes P450 (P450s) involved in…”
    Get full text
    Journal Article
  16. 16

    An update on metabolism studies using human hepatocytes in primary culture by Gómez-Lechón, María José, Castell, José V, Donato, María Teresa

    “…Cultured human hepatocytes are the closest in vitro model to human liver and constitute a very predictive model for drug metabolism in vivo. The variability…”
    Get more information
    Journal Article
  17. 17

    ATF5 Is a Highly Abundant Liver-Enriched Transcription Factor that Cooperates with Constitutive Androstane Receptor in the Transactivation of CYP2B6: Implications in Hepatic Stress Responses by PASCUAL, Maya, GOMEZ-LECHON, M. Jose, CASTELL, José V, JOVER, Ramiro

    Published in Drug metabolism and disposition (01-06-2008)
    “…Activating transcription factor (ATF) 5 is a member of the ATF/cAMP response element-binding protein family, which has been associated with differentiation,…”
    Get full text
    Journal Article
  18. 18

    Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach by Castell, José V., Teresa Donato, M., Gómez-Lechón, María José

    “…Lung is a target organ for the toxicity of inhalated compounds. The respiratory tract is frequently exposed to elevated concentrations of these compounds and…”
    Get full text
    Journal Article
  19. 19

    Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS by Gómez-Lechón, M.José, Ponsoda, Xavier, O’Connor, Enrique, Donato, Teresa, Castell, José V., Jover, Ramiro

    Published in Biochemical pharmacology (01-12-2003)
    “…Diclofenac is a non-steroidal anti-inflammatory drug that is widely used clinically but side effects associated with the administration of the drug have been…”
    Get full text
    Journal Article
  20. 20

    Allergic hepatitis induced by drugs by Castell, José V, Castell, Marta

    “…PURPOSE OF REVIEWTo examine recent advances in our understanding of how drugs can trigger a hypersensitivity reaction in the liver, how tolerance is lost, the…”
    Get full text
    Journal Article